ESPRESSo Trial Challenges "More Therapy, Earlier" Paradigm in Stroke Rehabilitation
Key Insights
The ESPRESSo trial found that high-intensity therapy starting within two weeks of stroke (search) did not improve hand and arm recovery beyond standard care, challenging the "more therapy, earlier" approach.
Sixty-four stroke (search) survivors received an extra 90 minutes of daily therapy for three weeks, but showed identical three-month outcomes to patients receiving standard care alone.
The study suggests early stroke (search) recovery is dominated by natural biological repair processes that cannot be enhanced by increasing therapy dose above standard care.
A groundbreaking clinical trial led by University of Auckland researchers has challenged a fundamental assumption in stroke (search) rehabilitation, finding that high-intensity therapy begun within two weeks of stroke does not improve hand and arm recovery beyond standard care. The findings, published in Brain Communications, question the widely held belief that "more therapy, earlier" leads to better outcomes.
The ESPRESSo (Enhancing Spontaneous Recovery after Stroke (search)) trial represents a significant shift in understanding stroke rehabilitation timing and intensity. Professor Winston Byblow, the University of Auckland neuroscientist who led the study, noted: "We saw substantial recovery in almost all patients, but without any benefit of having extra therapy."
Study Design and Methodology
The Phase IIa clinical trial, conducted at Auckland City Hospital between 2021 and 2024, enrolled 64 stroke (search) survivors in a single-site, randomized, assessor-blinded design. In a world-first for rehabilitation trials, patients were selected based on a key biomarker linked to their potential for hand and arm recovery, regardless of initial symptom severity.
Participants were randomly assigned to receive either video game-based exploratory movement therapy or conventional therapy, both delivered for 90 minutes per weekday over three weeks in addition to usual care. One group interacted with an immersive videogame-based digital platform that guided animated dolphins, orcas, or other aquatic creatures through gameplay using high-volume exploratory hand and arm movements.
Unexpected Results Challenge Current Practice
Despite receiving an extra 90 minutes of therapy daily for 15 days, neither intervention group demonstrated superior outcomes compared to a cohort receiving standard care alone. The extra-therapy patients showed marked improvement between study onset and therapy completion, with further smaller gains at the three-month primary endpoint. However, these outcomes matched those of a previous cohort at the same center who received only standard therapy.
"Our findings suggest that early recovery after stroke (search) is dominated by powerful biological repair processes, and increasing therapy dose over and above standard care very early after stroke, may not enhance those processes," Byblow explained.
Understanding Natural Recovery Patterns
The trial revealed that stroke (search) recovery follows a strikingly consistent pattern regardless of therapy type or additional intervention. Early stroke recovery is characterized by spontaneous biological processes, including changes in brain excitability, reorganization of neural circuits, and resolution of acute injury effects.
"This tells us that natural biological processes dominate recovery in the early phase after stroke (search)," said Byblow. "This doesn't mean rehabilitation isn't important, it most certainly is, but the timing, dose, and a patient's capacity to engage in therapy at the very early stage matter more than previously appreciated."
Clinical Implications and Future Directions
The results carry significant implications for stroke (search) rehabilitation service organization. Delivering intensive therapy immediately after stroke presents challenges even in well-resourced hospitals, as patients are often fatigued, medically unstable, and managing multiple rehabilitation priorities.
The study suggests that high-dose therapy may prove more effective later in recovery when patients can engage more fully, though potential gains may be smaller. "We may need to explore more biological treatments early rather than pushing patients harder with activity-based therapies alone. The activity-based therapy dose can be gradually increased over time," Byblow noted.
Digital Therapy Shows Promise
An encouraging finding emerged regarding digital rehabilitation tools. The video game-based therapy proved as effective as conventional therapy while being rated as more enjoyable by patients. "It is interesting to see that extra therapy can be delivered by using digital aids that are fun, engaging and rated as enjoyable by patients, with the same outcomes achieved as conventional therapy," Byblow observed.
Research Context and Funding
The ESPRESSo trial was prompted by dramatic improvements observed in animal studies using therapy doses and intensities far exceeding routine patient care. The international research team included collaborators from Johns Hopkins University (search), New York Medical College, UCLA, the University of Adelaide, and MindMaze SA (Switzerland). The Health Research Council of New Zealand funded the study.
The research addresses a critical clinical need, as persistent hand weakness (search) significantly reduces independence at six months post-stroke (search). The findings suggest that "the biggest gains from intensive training may come after early spontaneous recovery has run its course," according to Byblow.